Kartik Cherabuddi

Kartik Cherabuddi, MD, FACP

Associate Professor Of Medicine

Department: MD-INFECTIOUS DISEASES
Business Phone: (352) 294-5481
Business Email: cherabuddi@ufl.edu

About Kartik Cherabuddi

Dr. Kartik Cherabuddi provides clinical care to patients with complex infectious diseases; patients living with HIV; and internal medicine patients. He serves as a specialist for antibiotic resistant pathogen infections and is the Director of Antimicrobial Stewardship Program at UFHealth.

A Master Clinician Society at UF inductee, Dr. Cherabuddi is a recognized Exemplary Clinician for multiple years for excellence in teaching through the Department of Medicine. He enjoys teaching medical students, residents and ID fellows. He has been recognized as the DOM Attending of the year by the residents.

Dr. Cherabuddi conducts research looking at Antibiotic resistance and genetic sequencing of microorganisms. He also collaborates with researchers at the UF Emerging Pathogen Institute on (re)emerging viral infections including Zika, Chikungunya and Keystone viruses.

Dr. Cherabuddi also serves on international infectious diseases committees to develop enhanced training in Antibiotic Stewardship. He has advised and volunteered with education efforts around the world, including in Asia (India, Nepal) and Africa (Democratic Republic of Congo), in regards to COVID-19 control and management. He has given multiple interviews with national and international news media and continues education dispelling misinformation on social media platforms including Twitter @KartC.

Board Certifications

  • Infectious Diseases
    American Board of Multiple Specialties
  • Internal Medicine
    American Board of Internal Medicine

Clinical Profile

Specialties
  • Medicine
Subspecialties
  • Infectious Disease
Areas of Interest
  • HIV/AIDS
  • Infectious endocarditis
  • Osteomyelitis
  • Pseudomembranous colitis
  • Secondary infections
  • Surgical wound infection – treatment
  • Transplant services
  • Urinary tract infection – adults

Research Profile

Multidrug resistant infections

Antimicrobial alternatives to antibiotics

Therapeutic drug monitoring and personalized medicine

Emerging global infections

NTM infections in Transplant patients

Infectious disease fellow, Internal medicine resident and Medical student education

Open Researcher and Contributor ID (ORCID)

0000-0001-7390-9053

Publications

2021
Dissemination mechanisms of NDM genes in hospitalized patients.
JAC-antimicrobial resistance. 3(1) [DOI] 10.1093/jacamr/dlab032. [PMID] 34223104.
2021
Draft Genome Sequence of a Burkholderia cepacia Complex Strain Isolated from a Human Intra-abdominal Abscess.
Microbiology resource announcements. 10(11) [DOI] 10.1128/MRA.00091-21. [PMID] 33737360.
2021
In-Frame 12-Nucleotide Deletion within Open Reading Frame 3a in a SARS-CoV-2 Strain Isolated from a Patient Hospitalized with COVID-19.
Microbiology resource announcements. 10(8) [DOI] 10.1128/MRA.00137-21. [PMID] 33632859.
2021
India’s COVID-19 crisis: a call for international action.
Lancet (London, England). 397(10290):2132-2135 [DOI] 10.1016/S0140-6736(21)01121-1. [PMID] 34000256.
2021
Investing in the Future: A Role for Professional Societies to Prepare the Next Generation of Healthcare Leaders Through Curriculum Development and Dissemination.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 73(5):911-918 [DOI] 10.1093/cid/ciab244. [PMID] 33730751.
2021
Performance of a Semiquantitative Multiplex Bacterial and Viral PCR Panel Compared With Standard Microbiological Laboratory Results: 396 Patients Studied With the BioFire Pneumonia Panel.
Open forum infectious diseases. 8(1) [DOI] 10.1093/ofid/ofaa560. [PMID] 33447631.
2021
Relationship of Multiplex Molecular Pneumonia Panel Results With Hospital Outcomes and Clinical Variables.
Open forum infectious diseases. 8(8) [DOI] 10.1093/ofid/ofab368. [PMID] 34458392.
2021
Resource Over-Utilization in Hospitalized Patients With Uncomplicated Skin and Soft Tissue Infections.
Journal of pharmacy practice. [DOI] 10.1177/08971900211000216. [PMID] 33752488.
2021
Vaccine Enthusiasm and Hesitancy in Cancer Patients and the Impact of a Webinar.
Healthcare (Basel, Switzerland). 9(3) [DOI] 10.3390/healthcare9030351. [PMID] 33808758.
2020
Chloroquine and hydroxychloroquine in the context of COVID-19.
Drugs in context. 9 [DOI] 10.7573/dic.2020-4-5. [PMID] 32373183.
2020
Clostridioides difficile associated peritonitis in peritoneal dialysis patients – a case series based review of an under-recognized entity with therapeutic challenges.
BMC nephrology. 21(1) [DOI] 10.1186/s12882-020-01734-8. [PMID] 32131755.
2020
Early therapeutic monitoring of β-lactams and associated therapy outcomes in critically ill patients.
The Journal of antimicrobial chemotherapy. 75(12):3644-3651 [DOI] 10.1093/jac/dkaa359. [PMID] 32910809.
2020
Optimizing COVID-19 testing capabilities and clinical management using pathology informatics
JAMIA Open. 3(4):523-529 [DOI] 10.1093/jamiaopen/ooaa055.
2020
Population Pharmacokinetics and Target Attainment of Cefepime in Critically Ill Patients and Guidance for Initial Dosing.
Antimicrobial agents and chemotherapy. 64(9) [DOI] 10.1128/AAC.00745-20. [PMID] 32601155.
2020
Severe COVID-19 After Recent Heart Transplantation Complicated by Allograft Dysfunction.
JACC. Case reports. 2(9):1347-1350 [DOI] 10.1016/j.jaccas.2020.05.066. [PMID] 32835277.
2020
Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients.
medRxiv : the preprint server for health sciences. [DOI] 10.1101/2020.08.03.20167395. [PMID] 32793914.
2020
Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 100:476-482 [DOI] 10.1016/j.ijid.2020.09.025. [PMID] 32949774.
2019
Application of an objective structured clinical examination to evaluate and monitor intern’s proficiency of hand hygiene and personal protective equipment use in the United States.
Journal of educational evaluation for health professions. 16 [DOI] 10.3352/jeehp.2019.16.31. [PMID] 31614408.
2019
Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia Infections.
Antimicrobial agents and chemotherapy. 63(11) [DOI] 10.1128/AAC.00788-19. [PMID] 31427300.
2019
Keystone Virus Isolated From a Florida Teenager With Rash and Subjective Fever: Another Endemic Arbovirus in the Southeastern United States?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 68(1):143-145 [DOI] 10.1093/cid/ciy485. [PMID] 29893806.
2019
Prophylactic antibiotics in head and neck free flap surgery: A novel protocol put to the test.
American journal of otolaryngology. 40(6) [DOI] 10.1016/j.amjoto.2019.102276. [PMID] 31447185.
2018
Ampicillin for the treatment of complicated urinary tract infections caused by vancomycin-resistant Enterococcus spp (VRE): a single-center university hospital experience.
International journal of antimicrobial agents. 51(1):57-61 [DOI] 10.1016/j.ijantimicag.2017.06.008. [PMID] 28666756.
2018
Antifungal Potential of Host Defense Peptide Mimetics in a Mouse Model of Disseminated Candidiasis.
Journal of fungi (Basel, Switzerland). 4(1) [DOI] 10.3390/jof4010030. [PMID] 29495524.
2018
Antimicrobial Stewardship Training for Infectious Diseases Fellows: Program Directors Identify a Curriculum Need.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 67(8):1285-1287 [DOI] 10.1093/cid/ciy332. [PMID] 29668905.
2018
Assessing antimicrobial stewardship initiatives: Clinical evaluation of cefepime or piperacillin/tazobactam in patients with bloodstream infections secondary to AmpC-producing organisms.
International journal of antimicrobial agents. 52(5):719-723 [DOI] 10.1016/j.ijantimicag.2018.08.007. [PMID] 30125680.
2018
Peripheral T-cell lymphoma mimicking classic Hodgkin’s lymphoma in a patient presenting with fevers of unknown origin.
BMJ case reports. 2018 [DOI] 10.1136/bcr-2017-220858. [PMID] 29420242.
2018
Pertuzumab and trastuzumab infusion related cytokine release syndrome in a chemotherapy naive patient with metastatic breast cancer.
The breast journal. 24(3):383-384 [DOI] 10.1111/tbj.12943. [PMID] 29027290.
2018
SCAN: A novel approach for vancomycin time-out.
Infection control and hospital epidemiology. 39(12):1501-1503 [DOI] 10.1017/ice.2018.249. [PMID] 30303049.
2017
Potent in vitro and in vivo antifungal activity of a small molecule host defense peptide mimic through a membrane-active mechanism.
Scientific reports. 7(1) [DOI] 10.1038/s41598-017-04462-6. [PMID] 28659617.
2017
Refractory acute respiratory failure due to Pneumocystis jiroveci (PCP) and Cytomegalovirus (CMV) pneumonitis: A case report and review of literature.
IDCases. 10:42-45 [DOI] 10.1016/j.idcr.2017.08.011. [PMID] 28879093.
2017
Successful Treatment of Clostridium difficile Bacteremia with Aortic Mycotic Aneurysm in a Patient with Prior Endovascular Aortic Aneurysm Repair.
Case reports in infectious diseases. 2017 [DOI] 10.1155/2017/8472930. [PMID] 28348903.
2016
Case of eastern equine encephalitis presenting in winter.
BMJ case reports. 2016 [DOI] 10.1136/bcr-2016-215270. [PMID] 27165999.
2016
Zika and Chikungunya virus co-infection in a traveller returning from Colombia, 2016: virus isolation and genetic analysis.
JMM case reports. 3(6) [DOI] 10.1099/jmmcr.0.005072. [PMID] 28348794.
2014
Applying athletic principles to medical rounds to improve teaching and patient care.
Academic medicine : journal of the Association of American Medical Colleges. 89(7):1018-23 [DOI] 10.1097/ACM.0000000000000278. [PMID] 24979169.
2012
Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae: a multihospital study.
Infection control and hospital epidemiology. 33(12):1193-9 [DOI] 10.1086/668435. [PMID] 23143355.

Grants

Apr 2021 ACTIVE
CoVPN 3006 Protocol Funding (PF) – Gainesville Protocol-Specific Site
Role: Principal Investigator
Funding: FRED HUTCHINSON CANCER RES CTR via NATL INST OF HLTH NIAID
Feb 2021 ACTIVE
A randomized study to assess the efficacy of SARS-CoV-2 EUA vaccine in preventing SARS-CoV-2 infection and viral shedding in US college students
Role: Principal Investigator
Funding: FRED HUTCHINSON CANCER RES CTR via NATL INST OF HLTH NIAID
Oct 2018 – Dec 2020
CRBSI/CLABSI Infection Detection Project
Role: Principal Investigator
Funding: ARROW INTERNATIONAL
Feb 2018 – Nov 2019
A Phase 2 Proof-of-Concept Study to Evaluate the Efficacy and Safety of MEDI3902 in Mechanically Ventilated Patients for the Prevention of Nosocomial Pneumonia Caused by Pseudomonas aeruginosa
Role: Principal Investigator
Funding: DUKE UNIVERSITY MEDICAL CTR via NATL INST OF HLTH NIAID
Jan 2011 – Jan 2019
A Phase 2 Randomised, Double-blind, Placebo-controlled, Single-dose, Dose-ranging Study of the Efficacy and Safety of MEDI4893, a Human Monoclonal Antibody Against Staphylococcus aureus Alpha Toxin in Mechanically Ventilated Adult Subjects
Role: Principal Investigator
Funding: DUKE UNIVERSITY MEDICAL CTR via NATL INST OF HLTH NIAID

Education

Fellowship – Infectious Disease
2013 · University of Florida
Residency – Internal Medicine
2011 · Westlake Hospital
Residency – Internal Medicine
2010 · Westlake Hospital
Internship – Internal Medicine
2008 · Westlake Hospital
Bachelor of Medicine, Bachelor of Surgery
2004 · Kakatiya Medical College
Rotating Internship
2004 · Kakatiya Medical College

Teaching Profile

Courses Taught
2020
BMS6634 GI and Hepatology
2018
MDT7090 Elective Topics
2018
MDC7203 Senior Medicine Clerk
2018
MDC7124 Family Med/Geriatrics
2016,2018
MDC7200 Medicine Clerkship
2018
BMS6300 Fund Micro and Immuno
2016-2018
MDT7200 Elect Top/Medicine
2021
PAS5020 Intro to Medicine 2

Contact Details

Phones:
Business:
(352) 294-5481
Emails:
Business:
cherabuddi@ufl.edu